Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | (+-)-Quinacrine | HCID 237 | — |
| Reactant | Putrescine | HCID 1045 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | 3,9-Dichloro-7-methoxyacridine | HCID 66577 | — |
| Solvent | Phenol | HCID 996 | — |
| Product | 9-Aminoacridine | HCID 7019 | — |
Reaction Steps
A diamine side chain is first synthesized in a manner analogous to the side chain of quinacrine. Specifically, mono-phthaloyl protected 1,4-diaminobutane (27) is reacted with 6,9-dichloro-2-methoxyacridine (28) in phenol (J. Am. Chem. Soc. 66:1921-1924, 1944). The reaction mixture is then poured into an excess of 2N NaOH and extracted with ether. The ether extract is washed with 1M NaHCO3, then H2O, and dried over MgSO4. The crude product is recrystallized from H2O-alcohol. The phthaloyl protecting group is removed using anhydrous hydrazine in MeOH (Bioconjugate Chem. 2:435-440, 1991) to yield the aminoacridine, (29). Aminoacridine (29) is then conjugated with vitamin B12 monocarboxylic acid (2, 3, 4) to yield a cyanocobalamin-acridine conjugate (30).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05840880 |
|---|
| Source dataset | uspto-grants-1998_11 |
|---|
| ORD ID | ord-5763b93c92a34fe1be4724b64122f92d |
|---|
| Source note | uspto-grants-1998_11 |
|---|